Recombinant Anti-PROM1 × Anti-CD3 Bispecific Antibody (Tandem Diabody) (CAT#: TAND-LC022)

The anti-CD3/PROM1 antibody is a single chain diabody specifically targeting both CD133 and CD3. By recruiting T cell and therefore induce T cell killing, the bispecific antibody can be potentially used in the treatment of brain cancers such as glioblastoma.


Specific Inquiry
  • Size:
  • Conjugation:
  • Datasheet
  • MSDS
  • COA

Specifications

  • Target
  • PROM1 & CD3
  • Type
  • Tandem Diabody
  • Species Reactivity
  • Human
  • Target 1
  • PROM1
  • Host Species 1
  • Mouse
  • Target 2
  • CD3
  • Host Species 2
  • Human
  • Application
  • FuncS, Promising therapeutic agent
  • Related Disease
  • Glioblastoma

Target

  • Target 1
  • PROM1
  • Alternative Names
  • PROM1; prominin 1; RP41; AC133; CD133; MCDR2; STGD4; CORD12; PROML1; MSTP061; prominin-1; hProminin; antigen AC133; prominin-like protein 1; hematopoietic stem cell antigen
  • Target 2
  • CD3
  • Alternative Names
  • CD3; CD3 T-Cell Co-receptor;CD3D; CD3E; CD3G

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for TAND-LC022. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare